JD.Com Inc. is stepping up its international ambitions with a playbook that closely resembles Amazon's approach to overseas ...

India’s Section 107A (Bolar exemption) allows generics to conduct R&D on patented drugs for regulatory approval, accelerating ...

Discover the launch of the Ind–Aus Launchpad Programme, an innovative cross-border accelerator designed to fast-track biotech ...

NEW DELHI (Reuters) -India's merchandise trade deficit in July stood at $27.35 billion, according to a Reuters calculations ...

(Reuters) -India and China are discussing resuming border trade of domestic goods after more than five years, Bloomberg News ...

Pharmaceutical companies in China are increasingly turning to local reagent suppliers to reduce costs, delivery times, and ...

RTW Biotech Opportunities (RTW:138¢) is a specialist healthcare investor in innovative biotech and medtech companies. The closed-end fund has been successful, generating an annualised 10.1 per cent ...

Syngene International, a global research company, announced it will be establishing its first U.S. facility in Baltimore.

Over 500 companies, including Bharat Petroleum (BPCL) and IRCTC, are set to announce their quarterly earnings on August 13, ...

Net worth of several of India’s richest individual investors surged in June quarter as a stock market rebound helped recover ...

The India-based biotech company acquired the plant near Johns Hopkins Bayview Hospital in April for $36.5 million.

Reshma Kewalramani, the Mumbai-born CEO of Vertex Pharmaceuticals, secures a spot on Fortune's 2025 list of the 100 Most ...